Business Services Industry
AstraZeneca comes out fighting to quash fears over anti-cholesterol drug.
Knight Ridder/Tribune Business News, July, 2004
Daily Mail, London Knight Ridder/Tribune Business News
Jul. 23--AstraZeneca moved to quash fears over its key anti-cholesterol drug Crestor as it weighed in with better-than-expected second-quarter results.
The drugs giant has submitted a 30-page report to the US Food & Drugs Administration which it said shows Crestor is as safe as all the other so-called "statins" -- the class of drug -- currently on the market.
Controversy has dogged the treatment since the US consumer group Public Citizen said Crestor was more likely than rivals to produce the potentially muscle-wasting side effect called rhabdomyolysis which can be fatal.
This is the same problem which caused Bayer's Baycol fat-buster to be taken off sale.
...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Presented by American Express